aspA promoter as a tumor microenvironment-responsive autoswitch for anticancer agent expression in Escherichia coli. [PDF]
Lee D, Hong S, Kim J, Song M, Lim D.
europepmc +1 more source
Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β-Expressing Macrophages. [PDF]
Furusho Y +11 more
europepmc +1 more source
Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38. [PDF]
Luther N +9 more
europepmc +1 more source
Synergistic antitumor activity of anti-CD25 recombinant immunotoxin LMB-2 with chemotherapy. [PDF]
Singh R, Zhang Y, Pastan I, Kreitman RJ.
europepmc +1 more source
Evaluation of the Safety of A Novel Anti-HER2 Immunotoxin Containing Modified Fragment of <i>Pseudomonas</i> Exotoxin in BALB/C Mice. [PDF]
Saadatkhah F +4 more
europepmc +1 more source
Antimetabolites synergize with non-genotoxic antibody drug conjugate conditioning in hematopoietic stem cell lentiviral gene therapy. [PDF]
Okalova J +10 more
europepmc +1 more source
An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin. [PDF]
Narbona J +5 more
europepmc +1 more source
Comparison of two immunotoxins against DLL3 receptor; as an inhibitor for small cell lung cancer. [PDF]
Ataee MH +4 more
europepmc +1 more source
Bacterial Protein Toxins as Anticancer Agents: Clinical Potential of Pseudomonas and Anthrax Toxins. [PDF]
Misra R +6 more
europepmc +1 more source

